By Michael Balsamo and Ann D'Innocenzio

The Justice Department is suing Walmart, alleging the company unlawfully dispensed controlled substances through its pharmacies, helping to fuel the opioid crisis in America.

The civil complaint being filed Tuesday points to the role Walmart’s pharmacies may have played in the crisis by filling opioid prescriptions and by unlawfully distributing controlled substances to the pharmacies during the height of the opioid crisis. Walmart operates more than 5,000 pharmacies in its stores around the country.

The Justice Department alleges Walmart violated federal law by selling thousands of prescriptions for controlled substances that its pharmacists “knew were invalid,” said Jeffrey Clark, the acting assistant attorney general in charge of the Justice Department’s civil division.

Federal law required Walmart to spot suspicious orders for controlled substances and report those to the Drug Enforcement Administration, but prosecutors charge the company didn’t do that. Walmart couldn’t immediately be reached for comment.

“Walmart knew that its distribution centers were using an inadequate system for detecting and reporting suspicious orders,” said Jason Dunn, the U.S. attorney in Colorado. “As a result of this inadequate system, for years Walmart reported virtually no suspicious orders at all. In other words, Walmart’s pharmacies ordered opioids in a way that went essentially unmonitored and unregulated.”

The suit alleges that Walmart made it difficult for its pharmacists to follow the rules, putting “enormous pressure" on them to fill a high volume of prescriptions as fast as possible, while at the same time denying them the authority to categorically refuse to fill prescriptions issued by prescribers the pharmacists knew were continually issuing invalid prescriptions.

AP reported the news of the lawsuit ahead of the Justice Department's public announcement, citing a person who could not discuss the matter publicly before the announced move. The person spoke to the AP on condition of anonymity.

The Justice Department’s lawsuit comes nearly two months after Walmart filed its own preemptive suit against the Justice Department, Attorney General William Barr, and the Drug Enforcement Administration.

In its lawsuit, Walmart said the Justice Department’s investigation — launched in 2016 — had identified hundreds of doctors who wrote problematic prescriptions that Walmart’s pharmacists should not have filled. But the lawsuit charged that nearly 70% of the doctors still have active registrations with the DEA.

Walmart’s lawsuit alleged the government was blaming it for the lack of regulatory and enforcement policies to stem the crisis. The company is asking a federal judge to declare the suit has no basis to seek civil damages. That suit remains ongoing.

The initial investigation was the subject of a ProPublica story published in March. ProPublica reported that Joe Brown, then U.S. attorney for the Eastern District of Texas office, spent years pursuing a criminal case against Walmart for its opioid prescription practices, only to have it stymied after the retail giant’s lawyers appealed to senior officials in the Justice Department.

Two months later, Brown resigned. He didn’t give a reason for his departure except to say he would be “pursuing opportunities in the private and public sectors." Brown went into private practice in the Dallas area.

Updated on December 22, 2020, at 3:44 p.m. ET with additional details.

Share:
More In Business
Tesla Launches All-Electric Kids Cyberquad Vehicle
If your kid was on Santa's "nice list" this year, maybe you're willing to shell out $1,900 for Tesla's new Cyberquad. The automaker's all-electric ATV for children 8 years old and up is available to order now and is expected to begin shipping in two to four weeks.
Southeast Asia Superapp Grab CFO on Profitability, Growth as Company Goes Public
Grab, a Southeast Asia-based ride sharing, e-wallet, and delivery service, made its public debut on the Nasdaq via SPAC merger. CFO Peter Oey joined Cheddar's Brad Smith to talk about the IPO and why it was an ideal time for the company to go public. Oey noted that while Grab operates in 465 cities in eight Southeast Asian countries, there is still more opportunity to grow and expand while balancing profitability and growth.
Voltus Going Public In $1.3 Billion Deal
Voltus is going public by combining with a special purpose acquisition company, Broadscale Acquisition Corp., in a deal that values the electricity market technology startup at about $1.3 billion dollars. The company aims to deliver less expensive, more reliable, and more sustainable electricity to its more than 600 customers, including Home Depot, Coca-Cola, and Simon Property Group. Gregg Dixon, co-founder and CEO of Voltus and Andrew Shapiro, chairman and CEO of Broadscale Acquisition Corp., joined Cheddar News to discuss the deal.
Manufacturing Industry Outlook Amid Omicron, Supply Chain Issues
The Institute for Supply Management released its monthly manufacturing PMI report on Wednesday, showing growth in the manufacturing sector but demand continues to outpace production. Deborah Byers, EY Americas Industry Leader, joins Cheddar to discuss takeaways from this month's report, and what companies across industries are prioritizing going into 2022.
Load More